Literature DB >> 12654794

Attenuated Yersinia enterocolitica mutant strains exhibit differential virulence in cytokine-deficient mice: implications for the development of novel live carrier vaccines.

María S Di Genaro1, Marc Waidmann, Uwe Kramer, Niclas Hitziger, Erwin Bohn, Ingo B Autenrieth.   

Abstract

Yersinia enterocolitica mutant strains, including mutants deficient in the chaperone SycH resulting in a functional deficiency in tyrosine phosphatase (YopH), Mn-cofactored superoxide dismutase (SodA), iron-repressive protein 1 (IRP-1), and Yersinia adhesin A (YadA), were demonstrated to be highly attenuated in wild-type C57BL/6 mice. TNFRp55(-/-), IL-12p40(-/-), and IL-18(-/-) mutant mice, in which the Yersinia wild-type strain causes severe systemic infections, were used to investigate whether these Yersinia mutant strains would be attenuated in immunodeficient hosts. A plasmid-cured Yersinia mutant strain was unable to colonize any of the mutant mice tested. A SycH-deficient mutant strain colonized intestinal tissues of these mice but was attenuated for systemic infection in all of the mutant mice. Both YadA- and Irp-1-deficient Yersinia mutants were still attenuated in IL-12(-/-) and IL-18(-/-) mice but were pathogenic in TNFRp55(-/-) mice. By contrast, a Yersinia sodA mutant was highly pathogenic for TNFRp55(-/-) and IL-12p40(-/-) mice while interleukin-18 (IL-18) was dispensable. This finding demonstrates that certain virulence factors enable yersiniae to compete with distinct cytokine-dependent host defense mechanisms. Moreover, while gamma interferon mRNA expression did not reflect protective host responses in cytokine-deficient mice, IL-10 expression coincided with a heavy splenic bacterial load and was associated with progressive infection courses. We can thus segregate minor (SodA), intermediate (YadA and IRP-1), and major (YopH) virulence factors of Y. enterocolitica. Finally, we demonstrate that, even in immunocompromised hosts, Yersinia sycH and, with some restrictions, irp-1 mutants may be suitable for use as live carrier vaccines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654794      PMCID: PMC152075          DOI: 10.1128/IAI.71.4.1804-1812.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  57 in total

1.  Involvement of M cells in the bacterial invasion of Peyer's patches: a common mechanism shared by Yersinia enterocolitica and other enteroinvasive bacteria.

Authors:  A Grützkau; C Hanski; H Hahn; E O Riecken
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

Review 2.  Yersinia enterocolitica.

Authors:  T L Cover; R C Aber
Journal:  N Engl J Med       Date:  1989-07-06       Impact factor: 91.245

Review 3.  The role of IL-10 in crossregulation of TH1 and TH2 responses.

Authors:  T R Mosmann; K W Moore
Journal:  Immunol Today       Date:  1991-03

4.  Intracellular targeting of the Yersinia YopE cytotoxin in mammalian cells induces actin microfilament disruption.

Authors:  R Rosqvist; A Forsberg; H Wolf-Watz
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

5.  Reactive arthropathy following Salmonella vaccination.

Authors:  A Calin; N Goulding; D Brewerton
Journal:  Arthritis Rheum       Date:  1987-10

6.  Immunohistochemical and electron microscopic study of interaction of Yersinia enterocolitica serotype O8 with intestinal mucosa during experimental enteritis.

Authors:  C Hanski; U Kutschka; H P Schmoranzer; M Naumann; A Stallmach; H Hahn; H Menge; E O Riecken
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

7.  T lymphocytes mediate protection against Yersinia enterocolitica in mice: characterization of murine T-cell clones specific for Y. enterocolitica.

Authors:  I B Autenrieth; A Tingle; A Reske-Kunz; J Heesemann
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

8.  Yersinia outer protein P of Yersinia enterocolitica simultaneously blocks the nuclear factor-kappa B pathway and exploits lipopolysaccharide signaling to trigger apoptosis in macrophages.

Authors:  K Ruckdeschel; O Mannel; K Richter; C A Jacobi; K Trülzsch; B Rouot; J Heesemann
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

9.  Circulating yersinia specific immune complexes after acute yersiniosis: a follow up study of patients with and without reactive arthritis.

Authors:  R Lahesmaa-Rantala; K Granfors; R Kekomäki; A Toivanen
Journal:  Ann Rheum Dis       Date:  1987-02       Impact factor: 19.103

10.  Macrophage deactivation by interleukin 10.

Authors:  C Bogdan; Y Vodovotz; C Nathan
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Process of protein transport by the type III secretion system.

Authors:  Partho Ghosh
Journal:  Microbiol Mol Biol Rev       Date:  2004-12       Impact factor: 11.056

2.  The Yersinia enterocolitica invasin protein promotes major histocompatibility complex class I- and class II-restricted T-cell responses.

Authors:  O T Bühler; C A Wiedig; Y Schmid; G A Grassl; E Bohn; I B Autenrieth
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  Yersinia enterocolitica YopH-Deficient Strain Activates Neutrophil Recruitment to Peyer's Patches and Promotes Clearance of the Virulent Strain.

Authors:  Mabel N Dave; Juan E Silva; Ricardo J Eliçabe; María B Jeréz; Verónica P Filippa; Carolina V Gorlino; Stella Autenrieth; Ingo B Autenrieth; María S Di Genaro
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

4.  Yersinia enterocolitica adhesin A induces production of interleukin-8 in epithelial cells.

Authors:  Yvonne Schmid; Guntram A Grassl; Oliver T Bühler; Mikael Skurnik; Ingo B Autenrieth; Erwin Bohn
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

5.  Role of IFN-gamma and IL-6 in a protective immune response to Yersinia enterocolitica in mice.

Authors:  Gianluca Matteoli; Edda Fahl; Philipp Warnke; Steffen Müller; Michael Bonin; Ingo B Autenrieth; Erwin Bohn
Journal:  BMC Microbiol       Date:  2008-09-19       Impact factor: 3.605

6.  IL-12/23p40 overproduction by dendritic cells leads to an increased Th1 and Th17 polarization in a model of Yersinia enterocolitica-induced reactive arthritis in TNFRp55-/- mice.

Authors:  Andrea Constanza Mayordomo; Juan Eduardo Silva; Carolina Virginia Gorlino; José Luis Arias; Walter Berón; María Silvia Di Genaro
Journal:  PLoS One       Date:  2018-03-01       Impact factor: 3.240

Review 7.  Treatment of reactive arthritis with biological agents: a review.

Authors:  Huiqiong Zeng; Baiwei Luo; Yue Zhang; Zhongyu Xie; Zhizhong Ye
Journal:  Biosci Rep       Date:  2020-02-28       Impact factor: 3.840

8.  Yersinia enterocolitica targets cells of the innate and adaptive immune system by injection of Yops in a mouse infection model.

Authors:  Martin Köberle; Annegret Klein-Günther; Monika Schütz; Michaela Fritz; Susanne Berchtold; Eva Tolosa; Ingo B Autenrieth; Erwin Bohn
Journal:  PLoS Pathog       Date:  2009-08-14       Impact factor: 6.823

9.  New pathogen-specific immunoPET/MR tracer for molecular imaging of a systemic bacterial infection.

Authors:  Stefan Wiehr; Philipp Warnke; Anna-Maria Rolle; Monika Schütz; Philipp Oberhettinger; Ursula Kohlhofer; Leticia Quintanilla-Martinez; Andreas Maurer; Christopher Thornton; Frederic Boschetti; Gerald Reischl; Ingo B Autenrieth; Bernd J Pichler; Stella E Autenrieth
Journal:  Oncotarget       Date:  2016-03-08

10.  Yersinia pseudotuberculosis YopH targets SKAP2-dependent and independent signaling pathways to block neutrophil antimicrobial mechanisms during infection.

Authors:  Lamyaa Shaban; Giang T Nguyen; Benjamin D Mecsas-Faxon; Kenneth D Swanson; Shumin Tan; Joan Mecsas
Journal:  PLoS Pathog       Date:  2020-05-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.